Compound Evidence File
#EC-2026-0485
SNAP-8
Filed under Peptides. The bureau holds 199 laboratory returns for this compound from 83 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
83 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Nov 2025 | 1 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 25 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Jan 2026 | 7 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Jan 2026 | 5 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Mar 2026 | 16 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 2 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 24 Nov 2025 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Jun 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Nov 2025 | 5 Jan 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 9.9 | 8 Jan 2026 | 2 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 14 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 9.9 | 26 Feb 2026 | 16 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 15 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Jun 2026 | 12 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Jun 2026 | 24 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Jun 2026 | 22 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 9.9 | 2 Jul 2026 | 1 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Apr 2026 | 1 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Apr 2026 | 2 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 27 May 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.8 | 9.8 | 9.8 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 9.0 | 9.0 | 9.0 | 13 Jun 2025 | 13 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 9.0 | 9.0 | 9.0 | 16 Mar 2025 | 16 Mar 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.8 | 7.6 | 10.0 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 8.8 | 7.8 | 9.7 | 24 May 2026 | 24 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 8.7 | 8.7 | 8.7 | 3 Jun 2025 | 3 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.4 | 7.3 | 9.3 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.4 | 6.7 | 9.8 | 24 May 2026 | 24 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 5 | 8.4 | 6.7 | 10.0 | 27 Feb 2025 | 26 Jan 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 6 | 8.3 | 6.2 | 10.0 | 3 Jun 2025 | 17 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 | 20 Jun 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 2 | 8.1 | 6.7 | 9.5 | 16 Mar 2025 | 20 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 8 | 7.8 | 4.2 | 10.0 | 7 May 2025 | 25 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 7.8 | 7.5 | 8.1 | 7 May 2025 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.6 | 7.6 | 7.6 | 27 Feb 2025 | 27 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 7.4 | 7.1 | 7.8 | 24 May 2026 | 24 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 | 24 Apr 2025 |
| NexaphCASE #VI-2026-0944 | X | 9 | 7.2 | 5.0 | 10.0 | 3 Jul 2025 | 24 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 | 8 Jul 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 | 6 May 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 | 17 Dec 2024 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 1 | 6.8 | 6.8 | 6.8 | 2 Jul 2025 | 2 Jul 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 | 3 Jul 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 | 14 Jan 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 | 3 Jul 2025 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 6.7 | 6.1 | 7.2 | 8 Jul 2025 | 25 May 2026 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 6.7 | 6.7 | 6.7 | 16 Mar 2025 | 16 Mar 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 | 14 Jan 2025 |
| LSPLCASE #VI-2026-0523 | X | 2 | 6.5 | 5.9 | 7.0 | 2 Apr 2025 | 21 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 | 28 Mar 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 6 | 6.3 | 5.4 | 7.3 | 11 Jun 2025 | 21 May 2026 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 | 28 Mar 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Jun 2025 | 13 Jun 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 2 | 6.2 | 6.0 | 6.5 | 20 Jun 2025 | 21 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 | 17 Dec 2024 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 | 17 Dec 2024 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 | 3 Jul 2025 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 3 | 6.1 | 5.1 | 6.9 | 28 Mar 2025 | 26 Jan 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 | 14 Jan 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 | 28 Mar 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 5.7 | 5.7 | 5.7 | 16 Mar 2025 | 16 Mar 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 | 20 Jun 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 5.4 | 4.2 | 6.6 | 20 Jun 2025 | 23 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 | 13 Feb 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 2 | 5.1 | 4.6 | 5.6 | 7 May 2025 | 17 May 2026 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 4.9 | 3.3 | 6.6 | 2 Jul 2025 | 21 May 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 4.4 | 4.4 | 4.4 | 27 Feb 2025 | 27 Feb 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 4.1 | 2.0 | 6.2 | 20 Jun 2025 | 19 Jan 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 3.8 | 3.8 | 3.8 | 2 Apr 2025 | 2 Apr 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 3.6 | 3.6 | 3.6 | 6 May 2025 | 6 May 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 3.5 | 3.5 | 3.5 | 11 Jun 2025 | 11 Jun 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | X | 1 | 3.3 | 3.3 | 3.3 | 28 Mar 2025 | 28 Mar 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 3.3 | 3.3 | 3.3 | 21 May 2025 | 21 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.0 | 3.0 | 3.0 | 13 Feb 2025 | 13 Feb 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.8 | 2.8 | 2.8 | 6 May 2025 | 6 May 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 2.7 | 2.7 | 2.7 | 25 Apr 2025 | 25 Apr 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 2.7 | 2.7 | 2.7 | 8 Jul 2025 | 8 Jul 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 1.1 | 1.1 | 1.1 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for SNAP-8 alone.